Holdings of VanEck Biotech ETF
ISIN US92189F7261
VanEck ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 395.6M $ including 395.4M $ in equities, 100.0 %
- Positions
- 24 in 4 countries
- Top ten
- 70.3 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Amgen Inc | 166,568 | 60.3M $ | 15.25 % |
| 2 | Gilead Sciences Inc | 400,338 | 50.6M $ | 12.79 % |
| 3 | Vertex Pharmaceuticals Inc | 72,485 | 36M $ | 9.10 % |
| 4 | Regeneron Pharmaceuticals Inc | 39,388 | 24.6M $ | 6.21 % |
| 5 | REVOLUTION MEDICINES INC | 111,381 | 20.9M $ | 5.27 % |
| 6 | Argenx SE | 21,198 | 19.7M $ | 4.97 % |
| 7 | NATERA INC | 71,677 | 19.5M $ | 4.92 % |
| 8 | IQVIA Holdings Inc | 88,160 | 17M $ | 4.31 % |
| 9 | ALNYLAM PHARMACEUTICALS INC | 50,358 | 15.2M $ | 3.83 % |
| 10 | Biogen Inc | 66,394 | 14.3M $ | 3.63 % |
| 11 | MODERNA INC | 189,951 | 13.3M $ | 3.36 % |
| 12 | Illumina Inc | 71,334 | 12.5M $ | 3.17 % |
| 13 | United Therapeutics Corp | 20,628 | 11.2M $ | 2.83 % |
| 14 | BEONE MEDICINES LTD | 38,996 | 11.1M $ | 2.81 % |
| 15 | Insmed Inc | 99,048 | 10.6M $ | 2.67 % |
| 16 | Incyte Corp | 86,946 | 9.9M $ | 2.49 % |
| 17 | Neurocrine Biosciences Inc | 48,865 | 8.2M $ | 2.08 % |
| 18 | BioNTech SE | 82,542 | 7.7M $ | 1.94 % |
| 19 | ICON PLC | 43,319 | 7.5M $ | 1.90 % |
| 20 | Bio-Techne Corp | 86,310 | 6.1M $ | 1.54 % |
| 21 | Charles River Laboratories International Inc | 26,203 | 5.9M $ | 1.50 % |
| 22 | BioMarin Pharmaceutical Inc | 92,530 | 5.3M $ | 1.34 % |
| 23 | QIAGEN NV | 107,713 | 4.2M $ | 1.06 % |
| 24 | Tempus AI Inc | 67,091 | 3.9M $ | 0.98 % |
Sector breakdown
- Health care 79.6 %
- Unattributed 20.4 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 91.2 %
- Netherlands 5.0 %
- Germany 1.9 %
- Ireland 1.9 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 21 | 360.5M $ | 91.18 % |
| 2 | Netherlands | 1 | 19.7M $ | 4.97 % |
| 3 | Germany | 1 | 7.7M $ | 1.94 % |
| 4 | Ireland | 1 | 7.5M $ | 1.90 % |
Cite this page
Titelia. "Holdings of VanEck Biotech ETF". https://titelia.com/en/funds/S000034406